Twelve-Year Survival in a Patient With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension on Nifedipine Monotherapy.

Helgeson, Scott A; Enderby, Cher Y; Moss, John E; Gass, Jennifer M; Zeiger, Tonya K; Burger, Charles D

Helgeson, Scott A; Enderby, Cher Y; Moss, John E; Gass, Jennifer M; Zeiger, Tonya K; Burger, Charles D.

Afiliação

Helgeson SA; Department of Pulmonary and Critical Care Medicine, Mayo Clinic, Jacksonville, FL.
Enderby CY; Department of Pharmacy, Mayo Clinic, Jacksonville, FL.
Moss JE; Department of Pulmonary and Critical Care Medicine, Mayo Clinic, Jacksonville, FL.
Gass JM; Department of Laboratory Genetics and Genomics, Greenwood Genetic Center, SC.
Zeiger TK; Department of Pulmonary Medicine, Mayo Clinic, Jacksonville, FL.
Burger CD; Department of Pulmonary and Critical Care Medicine, Mayo Clinic, Jacksonville, FL.

Mayo Clin Proc Innov Qual Outcomes ; 3(3): 376-379, 2019 Sep.

Article em En | MEDLINE | ID: mdl-31485576

Palavras-chave

AVT, acute vasoreactivity testing; CCB, calcium channel blocker; CREST, calcinosis cutis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia; CTD, connective tissue disease; PAH, pulmonary arterial hypertension; PAOP, pulmonary arterial occlusion pressure; PVR, pulmonary vascular resistance; RHC, right heart catherization; SSc, systemic sclerosis; TTE, transthoracic echocardiogram; mPAP, mean pulmonary arterial pressure

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google